These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 25062783)

  • 1. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma.
    Foster JM; Usherwood T; Smith L; Sawyer SM; Xuan W; Rand CS; Reddel HK
    J Allergy Clin Immunol; 2014 Dec; 134(6):1260-1268.e3. PubMed ID: 25062783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
    J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients.
    Ismaila A; Corriveau D; Vaillancourt J; Parsons D; Stanford R; Su Z; Sampalis JS
    Curr Med Res Opin; 2014 Jul; 30(7):1417-25. PubMed ID: 24666139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence and usage patterns of inhaled corticosteroids-long-acting beta-agonists by using inhaler-monitoring technology.
    Stanford RH; Averell CM; Johnson PT; Buysman EK; Carlyle MH
    Allergy Asthma Proc; 2020 Jul; 41(4):256-264. PubMed ID: 32605696
    [No Abstract]   [Full Text] [Related]  

  • 5. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
    Chapman KR; Ringdal N; Backer V; Palmqvist M; Saarelainen S; Briggs M
    Can Respir J; 1999; 6(1):45-51. PubMed ID: 10202220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of salmeterol/fluticasone via single versus separate inhalers on exacerbations in severe/very severe COPD.
    Hagedorn C; Kässner F; Banik N; Ntampakas P; Fielder K
    Respir Med; 2013 Apr; 107(4):542-9. PubMed ID: 23337300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
    Stoloff SW; Stempel DA; Meyer J; Stanford RH; Carranza Rosenzweig JR
    J Allergy Clin Immunol; 2004 Feb; 113(2):245-51. PubMed ID: 14767437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trial.
    Hale EM; Greene G; Mulvey C; Mokoka MC; van Boven JFM; Cushen B; Sulaiman I; Brennan V; Lombard L; Walsh J; Plunkett S; McCartan TA; Kerr PJ; Reilly RB; Hughes C; Kent BD; Jackson DJ; Butler M; Counihan I; Hayes J; Faul J; Kelly M; Convery R; Nanzer AM; Fitzgerald JM; Murphy DM; Heaney LG; Costello RW;
    Lancet Respir Med; 2023 Jul; 11(7):591-601. PubMed ID: 36963417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to asthma controller medication regimens.
    Stempel DA; Stoloff SW; Carranza Rosenzweig JR; Stanford RH; Ryskina KL; Legorreta AP
    Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada.
    Ismaila AS; Risebrough N; Li C; Corriveau D; Hawkins N; FitzGerald JM; Su Z
    Respir Med; 2014 Sep; 108(9):1292-302. PubMed ID: 25175480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of salmeterol and fluticasone propionate alone and in combination on airway blood flow in patients with asthma.
    Mendes ES; Rebolledo P; Wanner A
    Chest; 2012 May; 141(5):1184-1189. PubMed ID: 21980058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Device type and real-world effectiveness of asthma combination therapy: an observational study.
    Price D; Roche N; Christian Virchow J; Burden A; Ali M; Chisholm A; Lee AJ; Hillyer EV; von Ziegenweidt J
    Respir Med; 2011 Oct; 105(10):1457-66. PubMed ID: 21612903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
    Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A
    Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-care utilization and costs with fluticasone propionate and fluticasone propionate/salmeterol in asthma patients at risk for exacerbations.
    Hagiwara M; Delea TE; Stanford RH
    Allergy Asthma Proc; 2014; 35(1):54-62. PubMed ID: 24433597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised controlled trial of the effect of a connected inhaler system on medication adherence in uncontrolled asthmatic patients.
    Moore A; Preece A; Sharma R; Heaney LG; Costello RW; Wise RA; Ludwig-Sengpiel A; Mosnaim G; Rees J; Tomlinson R; Tal-Singer R; Stempel DA; Barnes N
    Eur Respir J; 2021 Jun; 57(6):. PubMed ID: 33334936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
    Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N
    J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
    Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.